{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products PHBR Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K210858",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081231"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DLZ"
    ],
    "Summary Letter Date": "August 13, 2021",
    "Summary Letter Received Date": "March 23, 2021",
    "Submission Date": "March 22, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.3660"
    ],
    "Regulation Name(s)": [
        "Phenobarbital Test System"
    ],
    "Analyte Class(es)": [
        "tdm",
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Phenobarbital"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic heterogeneous competitive immunoassay",
        "Reflectance spectrophotometry"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Chemistry Products PHBR Slides assay for phenobarbital quantitation on VITROS 5600 Integrated System",
    "Indications for Use Summary": "Quantitative measurement of phenobarbital in serum and plasma (lithium heparin) to aid in diagnosis, treatment, and monitoring of phenobarbital use or overdose.",
    "fda_folder": "Toxicology"
}